Kodiak Sciences Files Shelf Prospectus For Offering; Size Not Disclosed
-SEC Filing
Stocks · News reference
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96
HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $58 to $96.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $126
HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $96 to $126.
Top 3 Health Care Stocks That May Collapse In Q4
Three healthcare stocks—Quantum-Si, Kodiak Sciences and Iovance—show overbought RSI readings above 80, warning momentum-focused investors.
MongoDB, Kodiak Sciences, Navitas Semiconductor, Boeing and Nvidia: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed lower on Monday, with the Dow Jones Industrial Average falling 0.67% to 51,481.51.
Gold Tumbles Over 3%; MongoDB Shares Move Lower
U.S. stocks fell Monday, led by a 150-point Nasdaq drop. Energy rose, communication services slid; Knorex and Kodiak surged, while MongoDB tumbled.
Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.